ProScan Imaging’s Worldcare Clinical (WCC) is a global imaging clinical research organization offering end-to-end imaging services in support of clinical trials. The company’s clients include Top 20 Pharma, mid-size pharmaceutical companies, and a broad spectrum of biotechnology and medical device companies. WCC has worked with thousands of sites in more than 60 countries on Phase I-IV clinical trials. The company has substantial experience across therapeutic areas (Oncology, Musculoskeletal, Cardiovascular, and Neurology), as well as in all imaging modalities.
Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WCC employs imaging expertise, innovative technology and operational excellence to maximize the precision and accuracy of a blinded independent central review of clinical trial data. With more than 20 years of experience across hundreds of studies, WCC provides sponsors with extensive scientific, regulatory, operational, and imaging management expertise in support of even the most complex study designs.
For more information please visit our website.